Has Shawntae Romanello received payments from drug or device companies?

Yes. Drug and device makers reported $9,282 in general payments to Shawntae Romanello across 538 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Shawntae Romanello did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Shawntae Romanello come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Shawntae Romanello

Psychiatric/Mental Health · Hamilton, OHNPI 1922531631

Payments from drug & device makers

$9,282in general payments, 2019–2025

Across 538 payments — averaging $17.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$2K
Alkermes, Inc.$2K
Otsuka America Pharmaceutical, Inc.$1K
Teva Pharmaceuticals USA, Inc.$931
AbbVie$650
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$631
plus $3K from 16 others

What the payments were for

Food & beverage$9,18599%
Education$971%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	66	$1,580
Alkermes, Inc.	124	$1,534
Otsuka America Pharmaceutical, Inc.	63	$1,243
Teva Pharmaceuticals USA, Inc.	44	$931
AbbVie	41	$650
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	45	$631
Lundbeck LLC	34	$534
Axsome Therapeutics, Inc.	8	$387
Vanda Pharmaceuticals Inc.	13	$325
Neurocrine Biosciences, Inc.	18	$324
E.r. Squibb & Sons, L.L.C.	29	$304
Idorsia Pharmaceuticals US Inc	7	$155
Ironshore Pharmaceuticals Inc.	8	$148
Tris Pharma Inc	14	$144
Sunovion Pharmaceuticals Inc.	8	$104
Supernus Pharmaceuticals, Inc.	4	$90
Takeda Pharmaceuticals U.S.A., Inc.	3	$51
Corium, LLC	3	$50
Collegium Pharmaceutical, Inc.	2	$34
Luye Pharma (USA) Ltd.	2	$31
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$19
Indivior Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,282 in reported general payments places this provider in the 95th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Invega SustennaPaliperidone Palmitate	44	$138,445
Invega TrinzaPaliperidone Palmitate	14	$129,407
Abilify MaintenaAripiprazole	26	$72,788
VraylarCariprazine Hcl	24	$32,258
CaplytaLumateperone Tosylate	15	$25,440
Lurasidone Hcl	48	$14,696
QuviviqDaridorexant Hcl	23	$11,573
Asenapine Maleate	16	$5,012
Aripiprazole	27	$4,628
Quetiapine Fumarate ErQuetiapine Fumarate	31	$1,945
Paliperidone ErPaliperidone	19	$1,924
Ziprasidone Hcl	32	$1,794
Quetiapine Fumarate	135	$1,612
Venlafaxine Hcl ErVenlafaxine Hcl	52	$1,553
Sertraline Hcl	64	$1,495

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza	$1,580	$267,85258 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena	$1,243	$72,78826 claims
AbbVieVraylar	$650	$32,25824 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta	$631	$25,44015 claims
Idorsia Pharmaceuticals US IncQuviviq	$155	$11,57323 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Hamilton

Crystal TravisJackson$333K
Kristina RoweIronton$253K
Patricia SparksPortsmouth$210K
Mary HallWarren$195K
Kassandra KornbauCanfield$170K
Terri PopovitzCincinnati$161K
Steven MatesDayton$121K
Robert ParsonsYoungstown$119K
Chriscia BaneChillicothe$115K
Rachael McLaughlinMaple Heights$114K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →